Diabetes is associated with impaired glucose metabolism in the presence of excess insulin. Glucose and fatty acids provide reducing equivalents to mitochondria to generate energy, and studies have reported mitochondrial dysfunction in type II diabetes patients. If mitochondrial dysfunction can cause diabetes, then we hypothesized that increased mitochondrial metabolism should render animals resistant to diabetes. This was confirmed in mice in which the heart-muscle-brain adenine nucleotide translocator isoform 1 (ANT1) was inactivated. ANT1-deficient animals are insulin-hypersensitive, glucose-tolerant, and resistant to high fat diet (HFD)-induced toxicity. In ANT1-deficient skeletal muscle, mitochondrial gene expression is induced in association with the hyperproliferation of mitochondria. The ANT1-deficient muscle mitochondria produce excess reactive oxygen species (ROS) and are partially uncoupled. Hence, the muscle respiration under nonphosphorylating conditions is increased. Muscle transcriptome analysis revealed the induction of mitochondrial biogenesis, down-regulation of diabetes-related genes, and increased expression of the genes encoding the myokines FGF21 and GDF15. However, FGF21 was not elevated in serum, and FGF21 and UCP1 mRNAs were not induced in liver or brown adipose tissue (BAT). Hence, increased oxidation of dietary-reducing equivalents by elevated muscle mitochondrial respiration appears to be the mechanism by which ANT1-deficient mice prevent diabetes, demonstrating that the rate of mitochondrial oxidation of calories is important in the etiology of metabolic disease. mitochondria | skeletal muscle | ANT1 | insulin sensitivity
Diabetes is associated with impaired glucose metabolism in the presence of excess insulin. Glucose and fatty acids provide reducing equivalents to mitochondria to generate energy, and studies have reported mitochondrial dysfunction in type II diabetes patients. If mitochondrial dysfunction can cause diabetes, then we hypothesized that increased mitochondrial metabolism should render animals resistant to diabetes. This was confirmed in mice in which the heart-muscle-brain adenine nucleotide translocator isoform 1 (ANT1) was inactivated. ANT1-deficient animals are insulin-hypersensitive, glucose-tolerant, and resistant to high fat diet (HFD)-induced toxicity. In ANT1-deficient skeletal muscle, mitochondrial gene expression is induced in association with the hyperproliferation of mitochondria. The ANT1-deficient muscle mitochondria produce excess reactive oxygen species (ROS) and are partially uncoupled. Hence, the muscle respiration under nonphosphorylating conditions is increased. Muscle transcriptome analysis revealed the induction of mitochondrial biogenesis, down-regulation of diabetes-related genes, and increased expression of the genes encoding the myokines FGF21 and GDF15. However, FGF21 was not elevated in serum, and FGF21 and UCP1 mRNAs were not induced in liver or brown adipose tissue (BAT). Hence, increased oxidation of dietary-reducing equivalents by elevated muscle mitochondrial respiration appears to be the mechanism by which ANT1-deficient mice prevent diabetes, demonstrating that the rate of mitochondrial oxidation of calories is important in the etiology of metabolic disease. mitochondria | skeletal muscle | ANT1 | insulin sensitivity M ultiple studies suggest that human diabetes and insulin resistance are accompanied by impaired mitochondrial oxidative metabolism. Studies of patients with type II diabetes have revealed that mitochondrial gene expression is generally down-regulated. In particular, the mitochondrial biogenesis transcription factor PGC-1α and its downstream transcriptional targets are lower in diabetics compared with controls (1) (2) (3) (4) ; the enzymatic activity of NADH dehydrogenase (complex I) is reduced by 40% in skeletal muscle biopsies from obese, insulin-resistant individuals (5); mitochondrial size is diminished in obesity and diabetes (5, 6) ; ADP-stimulated respiration is reduced in permeabilized muscle fibers from obese, diabetic individuals (7, 8) ; and skeletal muscle, which accounts for >80% of insulin-stimulated glucose disposal, has impaired mitochondrial oxidative phosphorylation (OXPHOS) in diabetics (9, 10) . Mitochondrial DNA (mtDNA) rearrangements (11, 12) and tRNA Leu(UUR) nucleotide (nt) 3243A > G (13) mutations have been linked to diabetes, and the tRNA Ile nt 4291T > C mutation has been associated with metabolic syndrome (14) .
In mitochondrial myopathy, muscle mitochondrial stress is associated with the induction of the myokines fibroblast growth factor 21 (FGF21) (15, 16) and growth differentiation factor 15 (GDF15) (17) . Elevated FGF21 and GDF15 are associated with diabetes and glucose intolerance (18, 19) but have been shown to reduce serum glucose and insulin levels (20) . Elevated FGF21 can act non-cell autonomously to induce uncoupling protein 1 (UCP1) in brown adipose tissue (BAT), resulting in increased mitochondrial oxidation of lipids (21) .
The mitochondrial inner membrane adenine nucleotide translocators (ANTs) exchange mitochondrial ATP for cytosolic ADP. The mouse has two major somatic ANT isoforms: ANT1, which is predominantly expressed in heart, muscle, and brain; and ANT2, which is expressed in all tissues except muscle (22) . Mice in which the ANT1 gene is deleted develop mitochondrial myopathy in association with the hyperproliferation of skeletal muscle mitochondria (23, 24 ).
Here we demonstrate that Ant1 −/− mice have a striking resistance to the metabolic toxicity of a high fat diet (HFD). This is associated with excessive proliferation of partially uncoupled skeletal muscle
Significance
Mitochondrial dysfunction is associated with type II diabetes and metabolic syndrome, but whether it is cause or consequence is debated. By showing that increased mitochondrial respiration can impart glucose tolerance, insulin sensitivity, and resistance to high fat diet (HFD) toxicity, we provide evidence that mitochondria contributes to the etiology of metabolic disease. Inactivation of adenine nucleotide translocator isoform 1 (ANT1) results in proliferation of partially uncoupled muscle mitochondrial respiration, creating a sink for excess calories. Although ANT1-deficient muscle induces expression of Fgf21, FGF21 level is not elevated in blood, and FGF21 and UCP1 mRNAs are not increased in liver or brown adipose tissue (BAT). If increased mitochondrial respiration prevents HFD toxicity, then decreased mitochondrial respiration may contribute to metabolic disease. mitochondria resulting in higher than normal muscle respiration levels. Although FGF21 and GDF15 mRNAs are induced in muscle, FGF21 is not elevated in blood nor are FGF21 or UCP1 mRNAs induced in liver or BAT. Hence, in Ant1 −/− mice, the high degree of insulin sensitivity, glucose tolerance, and resistance to HFD toxicity appears to be the result of the oxidation of excess carbohydrates and fats in the muscle mitochondria.
Results
Protection from HFD Toxicity in ANT1-Deficient Mice. Ant1 −/− mice are markedly resistant to the toxicity of a HFD surviving past 1 y, a timepoint at which 75% of the Ant1 +/+ mice had already died (Fig.  1A) . On a low fat diet (LFD) Ant1 −/− mice show a slight reduction in survival (Fig. S1A) . Ant1 −/− mice have a 17% and 12% lower body weight than Ant1 +/+ mice on a HFD (Fig. 1B) and LFD (Fig. S1B ), respectively. Because they have similar levels of fat mass on the two diets as evaluated by NMR, the weight difference must reside in a reduction of lean mass on HFD (Fig. 1C) and LFD (Fig. S1C) .
In 8-9-mo-old Ant1 −/− mice housed in metabolic cages on a HFD, there is a slight decrease in the respiratory exchange ratio (RER; VCO 2 /VO 2 ), indicating a greater reliance on lipid substrates than glycolytic substrates (Fig. 1D) . The LFD shifts this relationship, such that there is a 6% increase in RER in the Ant1 −/− mice during the first 6 h of the dark cycle, indicating a greater reliance on glycolytic substrates and greater metabolic flexibility (Fig. S1D) .
The Ant1 −/− mice on a HFD are 39% less active than Ant1
mice during the first 6 h of the light cycle and ∼33% less active during both 6-h phases of the dark cycle (Fig. 1E ). Ant1 −/− mice on a LFD have a similar 36% decrease in activity during the light phase and a 45% decrease across both dark phases (Fig. S1E) . Despite decreased activity, there was no difference in O 2 consumption or food intake between Ant1 −/− and Ant1 +/+ on either diet (Fig. S1 F-H) . Therefore, for the same amount of activity, the Ant1 −/− mice must consume more calories.
ANT1 Deficiency Promotes Glucose Tolerance and Insulin Sensitivity.
The fasting blood glucose levels of 9-mo-old Ant1 +/+ and Ant1 −/− on a HFD ( Fig. 2A ) and 24-mo-old Ant1 +/+ and Ant1 −/− mice on a LFD (Fig. S2A) showed no differences and fell within the euglycemic range of 60-120 mg/dL. However, the Ant1 −/− mice have a 45% and 24% reduction in fasting plasma insulin levels on HFD (Fig. 2B) and LFD (Fig. S2B) , respectively, indicating the Ant1 +/+ mice develop age-related and diet-induced insulin resistance while the Ant1 −/− mice are protected. When subjected to an i.p. glucose tolerance test (IPGTT), the Ant1 −/− mice showed faster glucose clearance than Ant1 +/+ mice when maintained on either the HFD ( Fig. 2A) or LFD (Fig. S2A) . During the IPGTT, the plasma insulin levels were 40-50% lower in Ant1
−/− mice maintained on both HFD (Fig. 2B ) and LFD (Fig.  S2B) . Thus, better glucose clearance was achieved in the Ant1 −/− mice with minimal secretion of insulin. This data suggest that firstphase insulin secretion was nearly absent in the Ant1 −/− pancreas, though Ant1 is not expressed in the pancreas or liver (22) .
For mice maintained on a HFD for 8-9 mo, subjection to a hyperinsulinemic-euglycemic clamp revealed that during hyperinsulinemia, Ant1 −/− mice had a 16% increase in the rate of glucose disposal (Rd) and their glucose infusion rate (GIR) was 65% , and 6-9 per group (C-E). *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. C-2-deoxyglucose uptake in white fat and skeletal muscle. Data are represented as mean ± SEM; n = 16-28 per group (A and B) and 7-9 per group (C and D). **P < 0.01; ***P < 0.001; ****P < 0.0001.
higher than those of Ant1 +/+ mice (Fig. 2C) . The Ant1 −/− mice on a LFD had a 48% higher Rd and a 65% higher GIR, revealing that Ant1 −/− mice are more insulin-sensitive (Fig. S2C ). To measure glucose uptake 14 C-2-deoxyglucose was injected into the mice during the hyperinsulinemic-euglycemic clamp. The white fat and skeletal muscle were removed from the animals, and the radiolabeled glucose in these tissues was counted. On a HFD, the Ant1 −/− mice displayed a trend of increased glucose uptake in the skeletal muscle (Fig. 2D) . On a LFD, Ant1 −/− mice had 70% more glucose uptake in the white adipose tissue (WAT) than the Ant1 +/+ mice but no difference in skeletal muscle uptake (Fig. S2D ).
Mitochondrial Proliferation in Skeletal Muscle. To assess the effects of the ANT1 defect on the skeletal muscle mitochondria, we isolated whole gastrocnemius from 12-mo-old Ant1 +/+ and Ant1 −/− mice fed a HFD. At the macroscopic level, the Ant1 −/− mice had darker skeletal muscle tissue, indicative of mitochondrial proliferation (25) (Fig. 3A) . The gastrocnemius muscle, which is composed of glycolytic (white) and oxidative (red) fibers, was redder in the Ant1 −/− mouse. Ultrastructural analysis by transmission electron microscopy revealed hyperproliferation of swollen mitochondria with disordered cristae in the Ant1 −/− mouse muscle. The intermyofibrillar compartment of the Ant1 +/+ mice have an ordered array of mitochondria with dense mitochondrial matrix along the Z-lines of the sarcomeres, whereas the Ant1 −/− mice exhibited hyperproliferation of abnormal mitochondria, which displaced the myofibrils (Fig. 3B) . Similarly, in the subsarcolemmal compartment, the Ant1 +/+ mice have a normal number of dense mitochondria, whereas the Ant1 −/− mice have numerous swollen mitochondria (Fig. 3B) .
To determine if the reddening of the Ant1 −/− muscle was due to conversion of glycolytic fibers into oxidative fibers, we analyzed cryosections for myosin heavy chain (MHC) isoforms type I, IIa, IIb, and IIx by immunohistochemistry (Fig. 3C ). In the Ant1 −/− white gastrocnemius muscle, there was an increase in oxidative type IIa, type IIx, and coexpressing type IIb/IIx fibers and a decrease in glycolytic type IIb fibers (Fig. 3D) . Hence, ANT1 deficiency caused a partial shift to more oxidative myofiber phenotypes.
Ant1
−/− Muscle Fiber Biochemistry. The striking resistance of Ant1 −/− mice to the toxicity of a HFD, together with the hyperproliferation of mitochondria, which oxidize pyruvate and fatty acids, suggests that the excess mitochondria may be protecting the mice from calorie overload. Consistent with this hypothesis, in 12-mo-old Ant1 −/− and Ant1 +/+ mice fed a HFD, the citrate synthase (CS), cytochrome c oxidase (COX, complex IV), and succinate dehydrogenase (SDH, complex II) activity levels per mg muscle protein were increased four-to sevenfold in white Ant1 −/− gastrocnemius (Fig. 4 A-C) and three-to fourfold in the red Ant1 −/− gastrocnemius ( Fig. S3 A-C) . Relative mtDNA content was increased two-to fourfold in white (Fig. 4D) and red (Fig. S3D ) gastrocnemius, respectively.
To assess mitochondrial function, bundles of white and red muscle fibers were dissected from the gastrocnemius, permeabilized with saponin, and the mitochondrial respiration was measured. The sequential addition of glutamate and malate (G/M, complex I substrates), ADP, and succinate (Succ, complex II substrate) revealed an approximate 60% and 80% reduction in state II and III respiration in Ant1 −/− versus Ant1 +/+ white and red muscle fibers when values were normalized by the specific activity of CS, indicative of activity per individual mitochondrion ( Fig. 4E and Fig. S3E ). These observations are consistent with limited ADP/ATP exchange due to the ANT1 deficiency.
However, when the G/M (complex I) respiration rates were normalized to muscle wet weight, the state II respiration rate, which represents respiration not linked to ATP synthesis, was increased in the Ant1 −/− muscle by 161% for white fibers ( Fig. 4F ) and 57% for red fibers (Fig. S3F ). When metabolizing G/M in the presence of ADP, the respiration rate was 14% lower in the Ant1 −/− white muscle fibers and 31% lower in the Ant1 −/− red muscle fibers, consistent with ANT1 deficiency inhibiting ADP import into the mitochondrion. However, when metabolizing both G/M and Succ in the presence of ADP (complex I and II), respiration per unit of muscle was 35% higher in Ant1 −/− white muscle fibers compared with Ant1 +/+ ( Fig. 4F ) and not significantly different between the Ant1 −/− and Ant1 +/+ red muscle fibers (Fig. S3F ). Finally, in the Ant1 −/− muscle, the respiratory control ratio (RCR, state III/state II respiration) was 56% and 67% of Ant1 +/+ in white and red muscle fibers, respectively, consistent with the electron transport chain being partially uncoupled from ATP synthesis ( Fig. S3 G and H) . The exact molecular mechanism for this apparent "uncoupling" is unknown, as it could result from nonspecific leak across the inner membrane, flickering of the mtPTP, or some other mechanism. However, the result is that the increased mitochondrial mass and the decoupling of mitochondrial OXPHOS from limiting ATP synthesis in the Ant1 −/− muscle more than offsets the respiratory defect resulting from impaired ADP/ATP exchange of the Ant1 −/− mitochondria, a result consistent with the increased oxygen consumption in Ant1 −/− mice. To assess the effect of ANT1 deficiency on muscle mitochondrial ROS production, mitochondrial H 2 O 2 production was quantified in permeabilized myofibers using Amplex Red, during the sequential addition of G/M, Succ, ADP, and antimycin a (AA). When metabolizing G/M, and normalized to CS, H 2 O 2 production was reduced 81% in Ant1 −/− white fibers ( represented as mean ± SEM; n = 2 per group. *P < 0.01; **P < 0.01.
was 47% lower in white fibers, indicating that individual Ant1 −/− mitochondria release less H 2 O 2 ( Fig. 4G and Fig. S3I ). By contrast, when H 2 O 2 production was normalized to muscle wet weight to reflect whole muscle mitochondrial H 2 O 2 production, the white and red muscle fiber H 2 O 2 production rates for G/M + Succ + ADP were 2-2.5-fold higher in Ant1 −/− muscle than Ant1 +/+ muscle ( Fig.  4H and Fig. S3J ).
White and red muscle fibers from Ant1 −/− gastrocnemius also had a three-to fourfold increase in free radical leak during ADPstimulated respiration ( Fig. 4I and Fig. S3K ), free radical leak being an estimate of the proportion of electrons reacting with oxygen to create reactive oxygen species (ROS) (26) . Hence, the cumulative muscle ROS production rate is increased in the Ant1 −/− muscle.
−/− muscle mitochondria are also acutely sensitive to Ca 2+ activation of the mitochondrial permeability transition pore (mtPTP) as quantified by the Ca 2+ retention capacity (CRC) (27) . CRC normalized per mitochondrial content was reduced 70-80% for both white and red fibers of the Ant1 −/− mouse, indicating increased predilection to mitochondrial permeability transition, perhaps the result of the chronically increased muscle ROS production ( Fig. 4J and Fig. S3L ).
Induction of FGF21 and GDF15 in Muscle but Not Liver or BAT and No Induction of UCP1. White gastrocnemius muscle RNA sequencing confirmed the absence of ANT1 (Slc25a4) mRNA (Fig. 5A and Table S1 ) and revealed the coordinate up-regulation of transcript levels of mitochondrial bioenergetics genes consistent with the hyperproliferation of mitochondria in ANT1-deficient skeletal muscle (Fig. S4A) . Although the average up-regulation of the nuclear DNA OXPHOS genes is modest, likely due to only some of the nuclear-coded OXPHOS proteins being rate limiting (Fig. 5B) , the up-regulation of the mtDNA-encoded OXPHOS genes is substantial (Fig. 5C ). The mtDNA complex IV transcripts are strongly up-regulated, as are the tRNA and rRNA transcripts (Fig. 5D) .
Consistent with the induction of mitochondrial bioenergetics genes, the mRNA for the transcriptional coactivator for nuclearcoded mitochondrial genes, peroxisome proliferator-activated receptor-γ coactivator (PGC)-1β (Ppargc1b), is up-regulated 2.46-fold, although the mRNAs for PGC-1α (Ppargc1a) and PGC-1-related coactivator (Pprc1) are down-regulated (Table S1 ). Rip140 (Nrip1), an inhibitor of mitochondrial biogenesis (28) , is also . (J) CRC in permeabilized white muscle fibers per unit of CS activity. Data are represented as mean ± SEM; n = 8 per group. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. down-regulated by nearly 50% (Table S1) . Additionally, the genes related to apoptosis, cell death, and polyamine metabolism are down-regulated (Fig. S4B) . Many transcripts of genes traditionally associated with diabetes are reduced in the Ant1 −/− white muscle. The mRNAs for insulin receptor substrates (IRS-1 and IRS-2), SHC2, PIK3CA, PDPK1, AKT3, GSK3B, and SGK1 are strongly reduced, as are the AMPK pathway gene transcripts PRKAB2, PRKACB, PRKAG3, and PRKAR1A (Table S1 ). The mRNAs for the transcriptional regulators FOXO1 and FOS are down-regulated, whereas the FOXO6 transcript level is up-regulated 6.91-fold. The glucose transporter mRNA GLUT1 (Slc2a1) is down-regulated, although GLUT4 (Slc2a4) is not, even though GLUT1 regulates basal glucose uptake while GLUT4 regulates insulin-mediated glucose uptake. Finally, PPARα (Ppara), which is implicated in FGF21 induction in liver (29) , is not induced in Ant1 −/− muscle (Table S1) .
Strikingly, the mRNA levels for myokines associated with mitochondrial myopathy and whole body energy homeostasis, FGF21 and GDF15 (15) (16) (17) , are strongly induced in skeletal muscle (Fig. S4 C and D) . FGF21 transcript is not detected in white gastrocnemius muscle of Ant1 +/+ mice, but it is increased 20-50-fold in Ant1 −/− mice on a LFD and HFD, respectively ( Fig.  5E and Fig. S4C ). GDF15 transcript is also up-regulated in gastrocnemius muscle 4-12-fold on a LFD and HFD, respectively (Fig. S4D) . By contrast, UCP1 mRNA levels in white gastrocnemius are unchanged (Fig. S4E) .
Although FGF21 mRNA is strongly induced in Ant1 −/− muscle (Fig. 5E) , the level of FGF21 in serum is decreased, not increased (Fig. 5F ). Moreover, FGF21 mRNA levels were not increased in liver, WAT, or BAT on either LFD or HFD (Fig. 5E and Fig.  S4C ). GDF15 mRNA was only increased in WAT on a LFD, not in liver and BAT on LFD, and GDF15 mRNA is down-regulated in BAT and WAT on a HFD (Fig. S4D) . Finally, Ucp1 expression was not significantly changed in muscle or BAT on a HFD, decreased in BAT on a LFD, and not significantly increased in liver or WAT on HFD, although expression was highly variable in WAT on a HFD, which could suggest variable beige fat formation ( Fig. 5E and Fig. S4E ). BDNF mRNA, which was up-regulated in gastrocnemius muscle, did not change in liver, WAT, or BAT on a HFD (Fig. S4F) .
Hence, the Ant1 −/− mouse resistance to a HFD does not appear to be the result of induction of FGF21 in liver, elevated FGF21 in serum, or the induction of Ucp1 in BAT, as reported for the PolgA D257A mutator mouse. Hence, the resistance to a HFD in the Ant1 −/− mouse appears to be increased substrate oxidation by the high levels of partially uncoupled mitochondria in the skeletal muscle, although increased respiration of WAT might also be a factor.
Discussion
Mice deficient in the heart-muscle-brain ANT isoform, ANT1, are resistant to hyperglycemia, hypersensitive to insulin, and resistant to HFD toxicity. Given that ANT1 deficiency results in reduced ATP/ADP exchange between the mitochondria and the cytosol, this observation might seem contrary to the hypothesis that mitochondrial dysfunction is central to the etiology of diabetes and metabolic syndrome. However, a detailed analysis of the cellular anatomy and physiology of the Ant1 −/− mouse revealed that ANT1 deficiency is associated with a dramatic compensatory hyperproliferation of partially uncoupled skeletal muscle mitochondria resulting in an overall increase in muscle mitochondrial oxidation of substrates, even in the absence of physical activity.
This protection of Ant1 −/− mice is not due to increased muscle insulin signaling, as the genes for these pathways are down-regulated. It is also not due to increased BAT hydrolysis of substrates due to the induction by high serum FGF21 or Ucp1 in BAT, as in the PolgA D257A mutator mouse (21), as the Ant1 −/− mouse serum FGF21 levels were reduced and Ucp1 is not induced in BAT. Therefore, because the muscle is the primary user of systemic glucose, the glucose tolerance and HFD resistance of the Ant1 −/− muscle is most likely due to increased muscle mitochondrial respiration, which depletes circulating glucose, nonesterified fatty acids, and triglycerides (30) . In the PolgA D257A mutator mouse, FGF21-mediated induction of Ucp1 with uncoupling of OXPHOS in BAT was proposed to remove the excess calories and account for increased insulin sensitivity and resistance to HFD-induced obesity (21) . Because the PolgA D257A mutator mouse accumulates abnormally high levels of mtDNA mutations in all tissues (31), increased metabolism of fats and glucose through muscle mitochondrial might also contribute to the glucose tolerance and insulin resistance of the PolgA D257A mutator mice, and skeletal muscle mitochondrial function was not analyzed in these animals.
In mice in which Ucp1 was ectopically expressed in muscle (Tg-HAS-UCP1), the partially uncoupled muscle mitochondria are associated with increased insulin sensitivity and resistance to a HFD (32) (33) (34) . Thus, like the Ant1 −/− mice, increased muscle mitochondrial respiration in the Tg-HAS-UCP1 mice rendered them resistant to high glucose and fat toxicity. This supports the notion that increased skeletal muscle mitochondrial respiration due to OXPHOS uncoupling can impart glucose tolerance, insulin sensitivity, and resistance to HFD toxicity.
Therefore, the high glucose tolerance, insulin sensitivity, and resistance to HFD toxicity of the Ant1 −/− mice is more analogous to that of the Tg-HAS-UCP1 mice. This similarity is further enhanced, as the knock-out of the Fgf21 gene in Tg-HAS-UCP1 mice did not abrogate their tendency to hypoglycemia and increased insulin sensitivity (35) .
As the PolgA
D257A
, Tg-HAS-UCP1, and Ant1 −/− mice all impart resistance to hyperglycemia and HFD through uncoupling of OXPHOS in muscle and/or WAT and BAT, then OXPHOS uncoupling must be the basis of their hypoglycemia insulin sensitivity and resistance to HFD. Given that increased mitochondrial respiration protects against excessive substrate toxicity, then the converse should also be true. Impaired mitochondrial OXPHOS should contribute to predisposition to diabetes, obesity, and metabolic syndrome. Modulation of mitochondrial function as an oxidative sink for substrates may thus provide a potential therapeutic strategy for metabolic diseases.
Materials and Methods

Mice. Male Ant1
−/− and Ant1 +/+ mice (C57BL/6JEiJ) were fed a LFD (13.5% kcal from fat; Purina LabDiet 5001) or a HFD (60% kcal from fat; Purina TestDiet 58G9). Food and water were provided ad libitum. Mice were maintained on a 13:11 h light-dark cycle. All procedures were approved by the Children's Hospital of Philadelphia Institutional Animal Care and Use Committee.
Metabolic Analysis. Body composition was measured by MRI (Echo Medical Systems). Mice were placed in a restraining device and scanned for 90 s. RER and activity were measured over 24 h in metabolic cages (CLAMS; Columbus Instruments) with ad libitum access to food and water.
Glucose Tolerance Test. Mice were fasted overnight for 12 h, and tail blood was collected for glucose and insulin levels. Following i.p. injection of glucose (1.5 g/kg), blood was collected at 20, 40, 60, 90, and 120 min. Glucose was measured using a glucometer (Bayer Ascensia Contour). Insulin was measured from heparinized plasma using an Ultra Sensitive Mouse Insulin ELISA Kit (Crystal Chem).
Electron Microscopy and Immunohistochemistry. For EM studies, gastrocnemius was isolated, and red and white fibers were immediately dissected and fixed with 2.5% (vol/vol) glutaraldehyde, 2.0% (vol/vol) paraformaldehyde in 0.1 M sodium cacodylate buffer, pH 7.4, overnight at 4°C. For IHC studies, the gastrocnemius, plantaris, and soleus complex was dissected as a whole and frozen in isopentane cooled in liquid nitrogen. Serial cross-sections were immunolabeled for MHC type I, IIa, IIb, and IIx (36).
Mitochondrial Enzyme Activity and mtDNA Content. Red and white gastrocnemius was dissected and frozen in liquid nitrogen. CS enzyme activity was determined by the change in absorbance of DTNB measured at 412 nm. COX enzyme activity was determined by the change in absorbance of reduced cytochrome c measured at 550 nm. SDH enzyme activity was determined by the change in absorbance of DCIP measured at 600 nm. Relative mtDNA content was measured by quantitative PCR using primers for ND1 and B2M.
Muscle Fiber Biochemistry. Respiration was performed in saponin permeabilized red and white gastrocnemius muscle fibers using an Oxygraph O2K (Oroboros Instruments) at 37°C. We added 10 mM glutamate, 5 mM malate, 2 mM ADP, and 10 mM Succ sequentially. ROS production was measured in permeabilized fibers using Amplex Red (ThermoFisher) at 37°C in a fluorometer. Then, 5 mM glutamate, 5 mM malate, 5 mM Succ, 2 mM ADP, and 10 μM AA were added sequentially. Excitation at 563 nm and emission at 587 nm was measured. CRC was measured in permeabilized fibers using Calcium Green (ThermoFisher) at 37°C in a fluorometer. Excitation at 505 nm and emission at 535 nm was measured (37) .
RNA-Seq and FGF21 and GDF15 Analysis. Total RNA from white gastrocnmeius was extracted with TRIzol and depleted of rRNA using RiboMinus (ThermoFisher). Libraries were prepared with Ion Library kit and sequenced using the Ion Proton Sequencer (ThermoFisher H] glucose was infused through the catheter at a rate of 0.05 μCi/min simultaneously with insulin (10 mU/kg/min). Tail blood was monitored for glucose at 10-min intervals for 3 h, and 20% (wt/vol) glucose was infused at an adjustable rate to achieve a blood glucose level of 120-140 mg/dL. One hour after initiation of infusion, 2-[ 14 C] deoxyglucose was injected i.v. to allow measurement of glucose uptake in tissues. The mice were euthanized, and gastrocnemius and perigonadal adipose tissue were harvested for measurement of glucose metabolites.
Electron Microscopy. Gastrocnemius was isolated, and red and white fibers were immediately dissected and fixed with 2.5% (vol/vol) glutaraldehyde, 2.0% (vol/vol) paraformaldehyde in 0.1 M sodium cacodylate buffer, pH 7.4, overnight at 4°C. After subsequent buffer washes, the samples were postfixed in 2.0% (wt/vol) osmium tetroxide for 1 h at room temperature and rinsed in distilled H 2 O before staining en bloc with 2% (vol/vol) uranyl acetate. After dehydration through a graded ethanol series, the muscle fibers were infiltrated and embedded in EMbed-812 (Electron Microscopy Sciences). Thin sections were stained with uranyl acetate and lead citrate and were examined on a JEOL 1010 electron microscope fitted with a Hamamatsu digital camera and AMT Advantage image capture software. Images of the intermyofibrillar compartment were collected at 12,000× magnification, and images from the subsarcolemmal compartment were collected at 15,000× magnification.
Immunohistochemistry. The gastrocnemius, plantaris, and soleus complex of each animal were dissected as a whole and mounted on plastic blocks in tragacanth and frozen in liquid isopentane cooled in liquid nitrogen. Samples were stored immersed in isopentane at -80°C until use. We cut 8 μm-thick serial cross-sections in a cryostat at −18°C and mounted them on lysine-coated slides to determine in situ fiber type. Two serial sections were used for the immunolabeling of the different MHCs. The first cross-sections of each sample were immunolabeled for MHC type I, IIa, and IIb. These cross-sections were first allowed to reach room temperature and rehydrated with PBS (pH 7.2). These sections were then blocked using goat serum [10% (vol/vol) in PBS] and incubated for 1 h at room temperature with the following primary antibody mixture: mouse IgG2b monoclonal anti-MHC type I (BA-F8, 1:25), mouse IgG1 monoclonal anti-MHC type IIa (SC-71, 1:200), mouse IgM monoclonal anti-MHC type IIb (BF-F3, 1:200), and rabbit IgG polyclonal anti-laminin (Sigma L9393, 1:750). Muscle cross-sections were then washed three times in PBS before being incubated for 1 h at room temperature with the following secondary antibody mixture: Alexa Fluor 350 IgG2b (y2b) goat antimouse (Invitrogen, A-21140, 1:500), Alexa Fluor 594 IgG1 (y1) goat anti-mouse (Invitrogen, A-21125, 1:100), Alexa Fluor 488 IgM goat anti-mouse (Invitrogen, A-21042, 1:500), and Alexa Fluor 488 IgG goat anti-rabbit (A-11008, 1:500). Muscle crosssections were then washed three times in PBS, and slides were then coverslipped using Prolong Gold (Invitrogen, P36930) as mounting medium. Identical procedures were used for the crosssection used to immunolabel for MHC type IIx, except for the primary antibody mixture, which was composed of a mouse IgM monoclonal anti-type 2x MHC (6H1, 1:25) and a rabbit IgG polyclonal anti-laminin, and the secondary antibody mixture, which was composed of Alexa Fluor 488 IgM goat anti-mouse and Alexa Fluor 488 IgG goat anti-rabbit.
Mitochondrial Enzyme Activity. Mice were euthanized by cervical dislocation and the gastrocnemius removed. We homogenized 15 to 25 mg of oxidative or glycolytic tissue with a Teflon pestle on ice in homogenization buffer (50 mM triethanolamine, 1 mM EDTA) at 4°C. CS enzyme activity was determined by the change in absorbance of DTNB (Ellman's reagent) measured at 412 nm. In a 96-well plate, 200 μL of CS assay mix (200 mM Tris, 10 mM acetyl-CoA, 10 mM DTNB, 10% Triton X-100), 7 μL of oxaloacetate (2 mM), and 10 μL of homogenate were added. Absorbance was read at 412 nm in kinetic mode. COX enzymatic activity was determined by the decrease in absorbance of reduced cytochrome c. In a 96-well plate, 2-10 μL of homogenate was added to 200 μL of COX assay mix (50 mM potassium phosphate, 10% n-Dodecylmaltoside, 0.1 mM reduced cytochrome c). Absorbance was read at 550 nm in kinetic mode. SDH enzyme activity was determined by the change in absorbance of DCIP (2,6-Dichloroindophenol) measured at 600 nm. In a 96-well plate, 200 μL of SDH assay mix (50 mM potassium phosphate, 2 mM EDTA, 50 mg/mL BSA, 20 mM KCN, 0.2 mM rotenone, 0.4 mM AA, 20 mM decylubiquinone, 20 mM DCIP, 500 mM Succ, 2 mM Tris, 50 mM ATP) was added to 5-10 μL of homogenate. Absorbance was read at 600 nm in kinetic mode.
Relative mtDNA Content. Gene expression was measured by quantitative real-time PCR. Total genomic DNA was extracted and purified (DNeasy, Qiagen) from ∼25 mg of isolated red and white gastrocnemius and diluted to 2.5 ng/μL. The ratio of mitochondrial to nuclear DNA (mtDNA/nDNA) was quantified by the 2-ΔΔC T method using the following primer pairs: for nDNA, β-2-microglobulin forward TCCTCTCCCGCTCTGCACCC (3′-5′) and reverse GGCGGGCCACCAAGGAGAAC; and mtDNA, ND1 forward GCAGAGACCAACCGAACCCCC and reverse GGGCCTGCGGCGTATTCGAT. The PCR mixture contained 1× iTaq Universal SYBR Green Supermix (BioRad), 400 nM primers, and 5 ng of template DNA.
Preparation of Permeabilized Muscle Fibers. Gastrocnemius muscles were rapidly dissected and immersed in ice-cold buffer (2.77 mM CaK 2 EGTA, 7.23 mM K 2 EGTA, 6.56 mM MgCl 2 , 0.5 mM DTT, 50 mM K-Mes, 20 mM imidazol, 20 mM taurine, 5.3 mM Na 2 ATP, 15 mM phosphocreatine, pH 7.3, at 4°C) in a Petri dish on ice. Muscle fiber bundles were prepared by teasing apart bundles along the fiber longitudinal orientation length of 3-4 mm, diameter of 1 mm. Using two sharpened forceps, each fiber bundle was gently dissected to maximize access to saponin. The muscle bundles were transferred to a scintillation vial containing 6 mL of buffer supplemented with 200 μL of saponin 30× (final concentration of 50 μg/mL). The bundles were incubated on ice on a rocking platform for 30 min.
Respiration of Permeabilized Muscle Fibers. Respiration was performed in permeabilized red and white gastrocnemius muscle fibers in an Oxygraph O2K (Oroboros Instruments) at 37°C in 2 mL of buffer (2.77 mM CaK 2 EGTA, 7.23 mM K 2 EGTA, 1.38 mM MgCl 2 , 0.5 mM DTT, 100 mM K-Mes, 20 mM imidazol, 20 mM taurine, 3 mM K 2 HPO 4 , 2 mg/mL BSA, pH 7.3, at 4°C). Muscle fiber bundles were weighed and added to the respiration chamber.
The following substrates were added sequentially: 10 mM glutamate, 5 mM malate, 2 mM ADP, and 10 mM Succ.
ROS Production in Permeabilized Muscle Fibers. Permeabilized red and white gastrocnemius muscle fibers were washed in buffer (110 mM K-Mes, 35 mM KCl, 1 mM EGTA, 3 mM MgCl 2 , 10 mM K 2 HPO 4 , 0.5 mM BSA, pH 7.3, at 4°C) and placed in a cuvette with assay mix (600 μL buffer, 3 μL Amplex Red, and 1.2 μL HRP) at 37°C into a fluorometer. The following substrates and inhibitors were added sequentially: 5 mM glutamate, 5 mM malate, 5 mM Succ, 2 mM ADP, and 10 μM AA. Excitation at 563 nm and emission at 587 nm was measured. The % free radical leak was calculated as the rate of H 2 O 2 production divided by twice the rate of O 2 consumption, as two electrons are needed to reduce 1 mol of O 2 to H 2 O 2 , whereas four electrons are transferred in the reduction of 1 mol of O 2 to water. The result was then multiplied by 100.
CRC Assay. Permeabilized red and white gastrocnemius muscle fibers were washed in buffer (250 mM sucrose, 5 μM EGTA-Tris, 10 mM Tris-Mops, pH 7.3, at 4°C) and placed in a cuvette with 600 μL CRC assay mix (10 mM P i , 2.5 mM malate, 5 mM glutamate, 0.5 nM oligomycin, 1 μM calcium green) at 37°C into a fluorometer. Excitation at 505 nm and emission at 535 nm was measured, and a single bolus of Ca 2+ was added. Fluorescence was recorded over 5-10 min.
RNA Sequencing. Total RNA was extracted and purified with TRIzol RNA Isolation Reagents and kits and depleted of cytosolic rRNA (RiboMinus, Life Technologies). RNA was quantified and its integrity checked on a Bioanalyzer 2100, RNA 6000 Nano kit (Eukaryote Total RNA Nano, Agilent Technologies), and Qubit 2.0 fluorometer RNA assay kit (Invitrogen). We used 500 ng of RNA for cDNA preparation, and libraries were prepared with Ion Library kit (Life Technologies) following manufacturer protocols, bar-coded with IonXpress RNA-Seq Barcode kit, and sequenced using the Life Technologies Ion Proton Sequencer with Ion OneTouch2 template preparation kit, Ion Proton Sequencing kit, and Ion PI Chip kit (Life Technologies). RNA sequencing data were further analyzed using Partek Genomics Suite software version 6.12.0109. Data were normalized and expressed as reads per kilobase per million reads (RPKM). Data were analyzed with DESeq and The Database for Annotation, Visualization and Integrated Discovery v6.7 (DAVID).
Quantitative Real-Time RT-PCR. Total RNA was isolated using TRIzol reagent (Thermo Fisher Scientific) according to the manufacturer's protocol. First-strand cDNA was created from total RNA using SuperScript IV First-Strand Synthesis System (Thermo Fisher Scientific). Quantitative RT-PCR was performed using TaqMan Expression Assays (Thermo Fisher Scientific) on the ViiA7 platform. The ΔΔCt method was used to normalize expression of the target gene to the control gene (mouse HPRT). The TaqMan primer sets are as follows: Hprt Mm00446968_m1, Fgf21 Mm00840165_g1, Gdf15 Mm00442228_m1, Bdnf Mm04230607_s1, and Ucp1 Mm01244861_m1.
FGF21 ELISA. Serum was collected from tail blood, and FGF21 levels were measured by ELISA (Millipore).
Statistical Analysis. Results are presented as means ± SEM. For comparison of two groups, Student's two-tailed t test was performed using GraphPad Prism version 5.04 (GraphPad Software). Mouse survival curves were generated using a Kaplan-Meier plot. P ≤ 0.05 was accepted for statistical significance. For RNA-seq data, P ≤ 0.01 was accepted for statistical significance. For gene expression by qPCR, Student's two-tailed t test was performed on the ΔC T values, and fold change [2(-ΔΔC T )] was graphed as geometric mean with 95% CIs. (E) Activity levels measured over 24 h in 8-9-mo-old mice fed a LFD. VO 2 rate during a 24-h period divided into four 6-h phases measured in 8-9-mo-old mice fed (F) a LFD or (G) a HFD. Data are represented as mean ± SEM; n = 12-30 per group (A and B) and 6-9 per group (C-G). *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. C-2-deoxyglucose uptake in white fat and skeletal muscle on LFD. Data are represented as mean ± SEM; n = 11-13 per group (A and B) and 7-9 per group (C and D). *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. . (L) CRC in permeabilized red muscle fibers per unit of CS activity. All data are means ± SEM; n = 8 per group. **P < 0.01; ***P < 0.001; ****P < 0.0001. versus Ant1 +/+ gastrocnemius (gastroc), liver, BAT, and WAT by qPCR. H, HFD; L, LFD. Data are represented as geometric mean with 95% CIs. n = 4 per group. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. The table includes individual transcripts of genes including adenine nucleotide translocases, insulin receptor signaling pathways, general transcription factors, and skeletal muscle secreted myokines. n = 4 mice per genotype. Statistical significance set to P < 0.01.
